Researchers at University of California San Diego School of Medicine report that autopsies of patients diagnosed with Alzheimer’s disease when they were alive — and confirmed by autopsy — indicate many cognitive issues symptomatic of the condition are less noticeable in living Hispanic patients.
Researchers at University of California San Diego School of Medicine found that a diet low in free sugars (those added to foods and beverages and occurring naturally in fruit juices) resulted in significant improvement in nonalcoholic fatty liver disease (NAFLD) in adolescent boys.
Early adult general cognitive ability is a stronger predictor of cognitive function and reserve later in life than other factors, such as higher education, occupational complexity or engaging in late-life intellectual activities.
An international group that includes researchers at University of California San Diego School of Medicine has identified 124 genetic variants associated with a person’s willingness to take risks, as reported in a study published January 14, 2019 in Nature Genetics.
For the first time, researchers at University of California San Diego have used rapid 3D printing technologies to create a spinal cord, then successfully implanted that scaffolding, loaded with neural stem cells, into sites of severe spinal cord injury in rats.
UC San Diego Health opens a state-of-the-art unit to treat seniors requiring emergency health care. The Gary and Mary West Emergency Department at UC San Diego Health in La Jolla is the first in California to treat qualifying patients over the age of 65 in a dedicated emergency care space.
As the San Diego Seals open their inaugural season, the professional box lacrosse team has selected UC San Diego Health, the region’s only academic health system, as its Official Health Care Provider.
In a new study using a mouse model, researchers at University of California San Diego School of Medicine suggest that long-term postpartum weight gain may be due not so much to retained fat as to reprogramming of maternal energy metabolism.
FDA approves first U.S. clinical trial of an intravenously administered bacteriophage-based therapy to treat resistant bacterial infections.
UC San Diego researchers have found a stem cell enzyme copy edits more than 20 tumor types, providing new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.